TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD. Marth K, Renner A, Pohl W. Respir Med 2021;182:106398.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Marth K, Renner A, Pohl W. TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD. Respir Med 2021;182:106398.
PMID: 33901786